Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 775

1.

Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study.

To KK, Yip CC, Lai CY, Wong CK, Ho DT, Pang PK, Ng AC, Leung KH, Poon RW, Chan KH, Cheng VC, Hung IF, Yuen KY.

Clin Microbiol Infect. 2018 Jun 12. pii: S1198-743X(18)30468-3. doi: 10.1016/j.cmi.2018.06.009. [Epub ahead of print]

PMID:
29906597
2.

Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.

Ng L, Chow AKM, Man JHW, Yau TCC, Wan TMH, Iyer DN, Kwan VHT, Poon RTP, Pang RWC, Law WL.

BMC Cancer. 2018 Jun 1;18(1):621. doi: 10.1186/s12885-018-4326-5.

3.

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.

Chau I, Park JO, Ryoo BY, Yen CJ, Poon R, Pastorelli D, Blanc JF, Kudo M, Pfiffer T, Hatano E, Chung HC, Kopeckova K, Phelip JM, Brandi G, Ohkawa S, Li CP, Okusaka T, Hsu Y, Abada PB, Zhu AX.

Br J Cancer. 2018 May 29. doi: 10.1038/s41416-018-0103-0. [Epub ahead of print]

PMID:
29808014
4.

Prevention of post-sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial.

Leung WK, But DY, Wong SY, Tong TS, Liu KS, Cheung KS, Tsang SH, Chok KS, Poon RT, Hung IF.

J Dig Dis. 2018 May 2. doi: 10.1111/1751-2980.12604. [Epub ahead of print]

PMID:
29722146
5.

Novel selective medium for the isolation of corynebacterium kroppenstedtii from heavily colonised clinical specimens.

Wong SCY, Poon RWS, Foo CH, Ngan AHY, Tse H, Lam VCM, Leung THY, Wong CP, Cheng VCC, Chen JHK, Yuen KY.

J Clin Pathol. 2018 Mar 28. pii: jclinpath-2017-204834. doi: 10.1136/jclinpath-2017-204834. [Epub ahead of print]

PMID:
29593062
6.

Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017.

Zhu H, Lee ACY, Li C, Mak WWN, Chen YY, Chan KH, Zhang AJX, Fung WF, Zhang RQ, Fung YF, Poon RWS, Lam JY, Tam S, Hung IFN, Chen H, Yuen KY, To KKW.

Emerg Microbes Infect. 2018 Mar 6;7(1):23. doi: 10.1038/s41426-018-0041-1.

7.

TRIP13 Functions in the Establishment of the Spindle Assembly Checkpoint by Replenishing O-MAD2.

Ma HT, Poon RYC.

Cell Rep. 2018 Feb 6;22(6):1439-1450. doi: 10.1016/j.celrep.2018.01.027.

8.

Fatal Talaromyces marneffei Infection in a Patient with Autoimmune Hepatitis.

Wong SCY, Sridhar S, Ngan AHY, Chen JHK, Poon RWS, Lau SKP, Woo PCY.

Mycopathologia. 2018 Jun;183(3):615-618. doi: 10.1007/s11046-017-0239-0. Epub 2018 Jan 18.

PMID:
29349620
9.

A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates.

Mercier KA, Al-Jazrawe M, Poon R, Acuff Z, Alman B.

Sci Rep. 2018 Jan 12;8(1):584. doi: 10.1038/s41598-017-18921-7.

10.

DISC1 Regulates Neurogenesis via Modulating Kinetochore Attachment of Ndel1/Nde1 during Mitosis.

Ye F, Kang E, Yu C, Qian X, Jacob F, Yu C, Mao M, Poon RYC, Kim J, Song H, Ming GL, Zhang M.

Neuron. 2017 Dec 6;96(5):1204. doi: 10.1016/j.neuron.2017.11.034. No abstract available.

11.

DISC1 Regulates Neurogenesis via Modulating Kinetochore Attachment of Ndel1/Nde1 during Mitosis.

Ye F, Kang E, Yu C, Qian X, Jacob F, Yu C, Mao M, Poon RYC, Kim J, Song H, Ming GL, Zhang M.

Neuron. 2017 Dec 6;96(5):1041-1054.e5. doi: 10.1016/j.neuron.2017.10.010. Epub 2017 Nov 2. Erratum in: Neuron. 2017 Dec 6;96(5):1204.

PMID:
29103808
12.

Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.

Ng KKC, Chok KSH, Chan ACY, Cheung TT, Wong TCL, Fung JYY, Yuen J, Poon RTP, Fan ST, Lo CM.

Br J Surg. 2017 Dec;104(13):1775-1784. doi: 10.1002/bjs.10677. Epub 2017 Nov 1.

PMID:
29091283
13.

Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions.

Tak WY, Lin SM, Wang Y, Zheng J, Vecchione A, Park SY, Chen MH, Wong S, Xu R, Peng CY, Chiou YY, Huang GT, Cai J, Abdullah BJJ, Lee JS, Lee JY, Choi JY, Gopez-Cervantes J, Sherman M, Finn RS, Omata M, O'Neal M, Makris L, Borys N, Poon R, Lencioni R.

Clin Cancer Res. 2018 Jan 1;24(1):73-83. doi: 10.1158/1078-0432.CCR-16-2433. Epub 2017 Oct 10.

PMID:
29018051
14.

PET imaging in anal canal cancer: a systematic review and meta-analysis.

Mahmud A, Poon R, Jonker D.

Br J Radiol. 2017 Dec;90(1080):20170370. doi: 10.1259/bjr.20170370. Epub 2017 Oct 3. Review.

PMID:
28972796
15.

Molecular identification of cestodes and nematodes by cox1 gene real-time PCR and sequencing.

Poon RWS, Tam EWT, Lau SKP, Cheng VCC, Yuen KY, Schuster RK, Woo PCY.

Diagn Microbiol Infect Dis. 2017 Nov;89(3):185-190. doi: 10.1016/j.diagmicrobio.2017.07.012. Epub 2017 Jul 29.

PMID:
28865743
16.

Corynebacterium kroppenstedtii Is an Emerging Cause of Mastitis Especially in Patients With Psychiatric Illness on Antipsychotic Medication.

Wong SCY, Poon RWS, Chen JHK, Tse H, Lo JYC, Ng TK, Au JCK, Tse CWS, Cheung IYY, Yuk MT, Luk WK, Yuen KY.

Open Forum Infect Dis. 2017 May 6;4(2):ofx096. doi: 10.1093/ofid/ofx096. eCollection 2017 Spring.

17.

A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease.

Palanimuthu D, Poon R, Sahni S, Anjum R, Hibbs D, Lin HY, Bernhardt PV, Kalinowski DS, Richardson DR.

Eur J Med Chem. 2017 Oct 20;139:612-632. doi: 10.1016/j.ejmech.2017.08.021. Epub 2017 Aug 9.

PMID:
28841514
18.

Synthesis and liquid-liquid extraction of non-agglomerated Al(OH)3 particles for deposition of cellulose matrix composite films.

Zhang T, Zhao X, Poon R, Clifford A, Mathews R, Zhitomirsky I.

J Colloid Interface Sci. 2017 Dec 15;508:49-55. doi: 10.1016/j.jcis.2017.08.026. Epub 2017 Aug 9.

PMID:
28818656
19.

Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.

Shek FH, Luo R, Lam BYH, Sung WK, Lam TW, Luk JM, Leung MS, Chan KT, Wang HK, Chan CM, Poon RT, Lee NP.

Cell Oncol (Dordr). 2017 Oct;40(5):443-456. doi: 10.1007/s13402-017-0332-x. Epub 2017 Jun 19.

PMID:
28631187
20.

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.

Chau I, Peck-Radosavljevic M, Borg C, Malfertheiner P, Seitz JF, Park JO, Ryoo BY, Yen CJ, Kudo M, Poon R, Pastorelli D, Blanc JF, Chung HC, Baron AD, Okusaka T, Bowman L, Cui ZL, Girvan AC, Abada PB, Yang L, Zhu AX.

Eur J Cancer. 2017 Aug;81:17-25. doi: 10.1016/j.ejca.2017.05.001. Epub 2017 Jun 4.

PMID:
28591675

Supplemental Content

Support Center